Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
68 studies found for:    Open Studies | "Bone Diseases, Infectious"
Show Display Options
Rank Status Study
21 Not yet recruiting Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: BCD-085;   Other: Placebo
22 Recruiting A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab (AIN457) to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: AIN457/Secukinumab;   Drug: AIN457/Secukinumab Placebo
23 Recruiting Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: BCD-055;   Biological: Remicade®
24 Recruiting The Effect of NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in the Spine in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: Golimumab;   Drug: Celecoxib
25 Recruiting Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: secukinumab 150mg
26 Recruiting Electroacupuncture for Relieving Pain in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Device: Electroacupuncture
27 Recruiting Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study
Conditions: Ankylosing Spondylitis;   Axial Spondyloarthritis
Intervention:
28 Not yet recruiting A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: ENIA11;   Biological: Placebo
29 Recruiting WEB-Based Physiotherapy for People With Axial Spondyloarthritis
Condition: Ankylosing Spondylitis
Intervention: Behavioral: Exercise
30 Not yet recruiting Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept (Half-Dose);   Drug: etanercept (Full-Dose);   Drug: Sulfasalazine;   Drug: Celecoxib
31 Recruiting An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
32 Recruiting Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA
Condition: Spondylitis, Ankylosing
Intervention: Biological: Etanercept
33 Recruiting Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo
Conditions: Axial Spondyloarthrithis;   Ankylosing Spondylitis
Interventions: Biological: Certolizumab Pegol;   Other: Placebo
34 Recruiting Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients
Condition: Ankylosing Spondylitis
Intervention: Drug: Adalimumab
35 Recruiting Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Condition: Ankylosing Spondylitis
Interventions: Drug: NSAIDs;   Drug: anti-TNF
36 Recruiting Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: TNF alpha;   Drug: NSAIDs and sulfasalazine
37 Recruiting An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
Condition: Nonradiographic Axial Spondylitis, Ankylosing
Interventions: Drug: Group 1: Placebo;   Drug: Group 2: Ustekinumab 45 mg;   Drug: Group 3: Ustekinumab 90 mg
38 Not yet recruiting Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression
Condition: Ankylosing Spondylitis
Interventions: Drug: Pamidronate;   Other: Placebo (NaCl 0.9%)
39 Recruiting An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
Condition: Spondylitis, Ankylosing
Interventions: Drug: Infliximab;   Drug: NSAIDs;   Drug: DMARDs
40 Recruiting Physical Training Program in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Personalized physical training program

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.